Argent Biopharma Limited has released a press release.
Contract Default Notice Issued To Varm Cosmo
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- MXC Signs Major Distribution Agreement for GMP Products
- Appendix 4E and Audited 2018 Financial Report
- MXC to Commence Australian Dementia Trial with Notre Dame
- Harvey Nichols Expands MGC Derma Distribution in the UK
- MXC Awarded GMP Certification & Manufacturing Licence
Later from Argent Biopharma
- Sale of MGC Derma to Strategic Partner Cannaglobal Canada
- CannEpil Authorised to Commence Australian Sales
- Response to ASX Price and Volume Query
- Definitive Agreement Signed for Sale of MGC Derma
- Legal Proceedings Commenced against Varm Cosmo
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma